TOP NEWS

Calcimedia Gets $6M

La Jolla-based CalciMedica, a developer of small molecule drugs for the treatment of inflammatory and autoimmune diseases, said Thursday that it has raised $6M in a tranche of financing, after initiating a Phase I clinical trial of a treatment for psoriasis. The funding came from all of its existing investors, including Sanderling Ventures, SR One and Biogen Idec New Ventures. The firm said the funding will allow it to complete its Phase 1 clinical trial by Q3 of 2011. More information »


RELATED COMPANIES


RELATED STORIES

MARKETPLACE

LATEST HEADLINES

More Headlines

BROWSE ISSUES